Ming Yi

机构：Southwest Medical University, Affiliated Hospital of Southwest Medical University, Hangzhou First People's Hospital, Tongji Hospital, First Affiliated Hospital Zhejiang University, Huazhong University of Science and Technology, Chongqing Three Gorges University, Zhejiang University · ORCID：0000-0001-5243-6613

发表论文 191 篇 · 总被引 15442 次 · h-index 56

代表论文

• Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021 (2025 · Journal of Hematology & Oncology · 被引 176)
• Tailoring traditional Chinese medicine in cancer therapy (2025 · Molecular Cancer · 被引 147)
• Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis (2025 · Journal of Hematology & Oncology · 被引 36)
• Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects (2025 · Acta Pharmaceutica Sinica B · 被引 32)
• Breaking barriers: The cGAS‐STING pathway as a novel frontier in cancer immunotherapy (2025 · 癌症：英文版 · 被引 25)
• Bispecific Antibody Targeting VEGF/TGF‐β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects (2025 · Advanced Science · 被引 18)